Clinical Trial of the TQB2930 Injection in Patients With Advanced Cancers

Clinical trial NCT05380882 · UNKNOWN

Trial details

NCT number: NCT05380882
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2022-05-01
Primary completion: 2023-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.